A Sustained Release Formulation of Novel Quininib-Hyaluronic Acid microneedles inhibits Angiogenesis and Retinal Vascular Permeability in vivo

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume57
Publication statusPublished - 1 Sep 2016

Cite this